Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$802M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$440M |
| 3 |
Meta Platforms (Facebook)
META
|
+$400M |
| 4 |
Uber
UBER
|
+$389M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.71B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$613M |
| 3 |
Apple
AAPL
|
+$478M |
| 4 |
Mastercard
MA
|
+$450M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$424M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Financials | 2.35% |
| 3 | Healthcare | 2.22% |
| 4 | Consumer Discretionary | 2.21% |
| 5 | Communication Services | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
CALL
10x Genomics
TXG
$7.31B
| $10.5M | ﹤0.01% |
70,600
+30,900
| +78% | +$4.73M |
|
|
GMS
2902
DELISTED
GMS Inc
GMS
| $10.5M | ﹤0.01% |
174,600
+78,609
| +82% | +$4.24M |
|
2903
PUT
Wingstop
WING
$3.44B
| $10.5M | ﹤0.01% |
60,700
-23,600
| -28% | -$3.96M |
|
2904
Northrop Grumman
NOC
$83.2B
| $10.5M | ﹤0.01% |
27,076
+13,055
| +93% | +$4.86M |
|
2905
CALL
Otis Worldwide
OTIS
$27.6B
| $10.5M | ﹤0.01% |
120,300
+35,500
| +42% | +$2.97M |
|
2906
NeoGenomics
NEO
$2.05B
| $10.5M | ﹤0.01% |
306,869
+274,192
| +839% | +$10.7M |
|
|
NKLA
2907
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
| $10.5M | ﹤0.01% |
35,357
+4,500
| +15% | +$1.5M |
|
2908
AMN Healthcare
AMN
$1.34B
| $10.5M | ﹤0.01% |
85,509
+69,762
| +443% | +$7.75M |
|
2909
CALL
MasTec
MTZ
$23.9B
| $10.4M | ﹤0.01% |
113,200
+26,600
| +31% | +$2.43M |
|
2910
PUT
GXO Logistics
GXO
$5.59B
| $10.4M | ﹤0.01% |
114,900
-37,500
| -25% | -$3.37M |
|
|
MON
2911
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
| $10.4M | ﹤0.01% |
1,069,035
-1,585
| -0.1% | -$15.5K |
|
|
YTPG
2912
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $10.4M | ﹤0.01% |
1,064,595
-496,292
| -32% | -$4.9M |
|
|
EAC
2913
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
| $10.4M | ﹤0.01% |
1,066,122
+1,931
| +0.2% | +$18.9K |
|
2914
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $10.4M | ﹤0.01% |
70,157
+45,403
| +183% | +$6.72M |
|
2915
Lloyds Banking Group
LYG
$90.1B
| $10.4M | ﹤0.01% |
4,079,808
+2,486,725
| +156% | +$6.34M |
|
2916
PUT
Enterprise Products Partners
EPD
$84B
| $10.4M | ﹤0.01% |
473,500
-301,900
| -39% | -$6.77M |
|
2917
Vale
VALE
$58B
| $10.4M | ﹤0.01% |
741,639
-1,749,127
| -70% | -$23.2M |
|
2918
PUT
PennyMac Financial
PFSI
$4.05B
| $10.4M | ﹤0.01% |
148,900
-151,600
| -50% | -$10M |
|
2919
Healthcare Services Group
HCSG
$1.48B
| $10.4M | ﹤0.01% |
583,998
+384,413
| +193% | +$7.48M |
|
2920
Bionano Genomics
BNGO
$13.9M
| $10.4M | ﹤0.01% |
5,790
+5,354
| +1,228% | +$14.3M |
|
2921
PUT
Olin
OLN
$2.18B
| $10.4M | ﹤0.01% |
180,300
-46,600
| -21% | -$2.61M |
|
2922
Maravai LifeSciences
MRVI
$849M
| $10.4M | ﹤0.01% |
247,303
-1,070,096
| -81% | -$43.3M |
|
2923
CALL
iQIYI
IQ
$1.3B
| $10.4M | ﹤0.01% |
2,271,300
+561,600
| +33% | +$3.97M |
|
2924
CALL
Synchrony
SYF
$26.4B
| $10.4M | ﹤0.01% |
223,200
-74,100
| -25% | -$3.56M |
|
2925
CALL
Lamb Weston
LW
$7.3B
| $10.3M | ﹤0.01% |
163,300
+96,300
| +144% | +$5.56M |
|
Similar funds
Ken Griffin's Q4 2021 Portfolio in Review
As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.
- Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
- Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
- Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
- Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
- Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
- Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
- Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.
Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.